Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions

CREBBP-BCORL1 and KDM2A-WWTR1

Yu-Chien Kao, Yun Shao Sung, Lei Zhang, Chun Liang Chen, Shih Chiang Huang, Cristina R. Antonescu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Ossifying fibromyxoid tumor (OFMT) is an uncommon mesenchymal neoplasm of uncertain differentiation and intermediate malignant potential. Recurrent gene fusions involving either PHF1 or BCOR have been found in 85% of OFMT, including typical and malignant examples. As a subset of OFMT still lack known genetic abnormalities, we identified two OFMTs negative for PHF1 and BCOR rearrangements, which were subjected to transcriptome analysis for fusion discovery. The RNA sequencing found a novel CREBBP-BCORL1 fusion candidate in an axillary mass of a 51 year-old male and a KDM2A-WWTR1 in a thigh mass of a 36 year-old male. The gene fusions were validated by RT-PCR and FISH in the index cases and then screened by FISH on 4 additional OFMTs lacking known fusions. An identical CREBBP-BCORL1 fusion was found in an elbow tumor from a 30 year-old male. Both OFMTs with CREBBP-BCORL1 fusions had areas of typical OFMT morphology, exhibiting uniform round to epithelioid cells arranged in cords or nesting pattern in a fibromyxoid stroma. The OFMT with KDM2A-WWTR1 fusion involved dermis and superficial subcutis, being composed of ovoid cells in a fibromyxoid background with hyalinized giant rosettes. The S100 immunoreactivity ranged from very focal to absent. Similar to other known fusion genes in OFMT, BCORL1, CREBBP and KDM2A are also involved in histone modification. In summary, we expand the spectrum of molecular abnormalities in OFMT with 2 novel fusions, CREBBP-BCORL1 and KDM2A-WWTR1, further implicating the epigenetic deregulation as the leading pathogenetic mechanism in OFMT.

Original languageEnglish
Pages (from-to)42-50
Number of pages9
JournalGenes Chromosomes and Cancer
Volume56
Issue number1
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Gene Fusion
Neoplasms
Histone Code
RNA Sequence Analysis
Epithelioid Cells
Gene Expression Profiling
Dermis
Elbow
Thigh
Epigenomics
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Cite this

Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions : CREBBP-BCORL1 and KDM2A-WWTR1. / Kao, Yu-Chien; Sung, Yun Shao; Zhang, Lei; Chen, Chun Liang; Huang, Shih Chiang; Antonescu, Cristina R.

In: Genes Chromosomes and Cancer, Vol. 56, No. 1, 01.01.2017, p. 42-50.

Research output: Contribution to journalArticle

Kao, Yu-Chien ; Sung, Yun Shao ; Zhang, Lei ; Chen, Chun Liang ; Huang, Shih Chiang ; Antonescu, Cristina R. / Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions : CREBBP-BCORL1 and KDM2A-WWTR1. In: Genes Chromosomes and Cancer. 2017 ; Vol. 56, No. 1. pp. 42-50.
@article{a954e21486224f8bab0793dcbaa26283,
title = "Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1",
abstract = "Ossifying fibromyxoid tumor (OFMT) is an uncommon mesenchymal neoplasm of uncertain differentiation and intermediate malignant potential. Recurrent gene fusions involving either PHF1 or BCOR have been found in 85{\%} of OFMT, including typical and malignant examples. As a subset of OFMT still lack known genetic abnormalities, we identified two OFMTs negative for PHF1 and BCOR rearrangements, which were subjected to transcriptome analysis for fusion discovery. The RNA sequencing found a novel CREBBP-BCORL1 fusion candidate in an axillary mass of a 51 year-old male and a KDM2A-WWTR1 in a thigh mass of a 36 year-old male. The gene fusions were validated by RT-PCR and FISH in the index cases and then screened by FISH on 4 additional OFMTs lacking known fusions. An identical CREBBP-BCORL1 fusion was found in an elbow tumor from a 30 year-old male. Both OFMTs with CREBBP-BCORL1 fusions had areas of typical OFMT morphology, exhibiting uniform round to epithelioid cells arranged in cords or nesting pattern in a fibromyxoid stroma. The OFMT with KDM2A-WWTR1 fusion involved dermis and superficial subcutis, being composed of ovoid cells in a fibromyxoid background with hyalinized giant rosettes. The S100 immunoreactivity ranged from very focal to absent. Similar to other known fusion genes in OFMT, BCORL1, CREBBP and KDM2A are also involved in histone modification. In summary, we expand the spectrum of molecular abnormalities in OFMT with 2 novel fusions, CREBBP-BCORL1 and KDM2A-WWTR1, further implicating the epigenetic deregulation as the leading pathogenetic mechanism in OFMT.",
author = "Yu-Chien Kao and Sung, {Yun Shao} and Lei Zhang and Chen, {Chun Liang} and Huang, {Shih Chiang} and Antonescu, {Cristina R.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1002/gcc.22400",
language = "English",
volume = "56",
pages = "42--50",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions

T2 - CREBBP-BCORL1 and KDM2A-WWTR1

AU - Kao, Yu-Chien

AU - Sung, Yun Shao

AU - Zhang, Lei

AU - Chen, Chun Liang

AU - Huang, Shih Chiang

AU - Antonescu, Cristina R.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Ossifying fibromyxoid tumor (OFMT) is an uncommon mesenchymal neoplasm of uncertain differentiation and intermediate malignant potential. Recurrent gene fusions involving either PHF1 or BCOR have been found in 85% of OFMT, including typical and malignant examples. As a subset of OFMT still lack known genetic abnormalities, we identified two OFMTs negative for PHF1 and BCOR rearrangements, which were subjected to transcriptome analysis for fusion discovery. The RNA sequencing found a novel CREBBP-BCORL1 fusion candidate in an axillary mass of a 51 year-old male and a KDM2A-WWTR1 in a thigh mass of a 36 year-old male. The gene fusions were validated by RT-PCR and FISH in the index cases and then screened by FISH on 4 additional OFMTs lacking known fusions. An identical CREBBP-BCORL1 fusion was found in an elbow tumor from a 30 year-old male. Both OFMTs with CREBBP-BCORL1 fusions had areas of typical OFMT morphology, exhibiting uniform round to epithelioid cells arranged in cords or nesting pattern in a fibromyxoid stroma. The OFMT with KDM2A-WWTR1 fusion involved dermis and superficial subcutis, being composed of ovoid cells in a fibromyxoid background with hyalinized giant rosettes. The S100 immunoreactivity ranged from very focal to absent. Similar to other known fusion genes in OFMT, BCORL1, CREBBP and KDM2A are also involved in histone modification. In summary, we expand the spectrum of molecular abnormalities in OFMT with 2 novel fusions, CREBBP-BCORL1 and KDM2A-WWTR1, further implicating the epigenetic deregulation as the leading pathogenetic mechanism in OFMT.

AB - Ossifying fibromyxoid tumor (OFMT) is an uncommon mesenchymal neoplasm of uncertain differentiation and intermediate malignant potential. Recurrent gene fusions involving either PHF1 or BCOR have been found in 85% of OFMT, including typical and malignant examples. As a subset of OFMT still lack known genetic abnormalities, we identified two OFMTs negative for PHF1 and BCOR rearrangements, which were subjected to transcriptome analysis for fusion discovery. The RNA sequencing found a novel CREBBP-BCORL1 fusion candidate in an axillary mass of a 51 year-old male and a KDM2A-WWTR1 in a thigh mass of a 36 year-old male. The gene fusions were validated by RT-PCR and FISH in the index cases and then screened by FISH on 4 additional OFMTs lacking known fusions. An identical CREBBP-BCORL1 fusion was found in an elbow tumor from a 30 year-old male. Both OFMTs with CREBBP-BCORL1 fusions had areas of typical OFMT morphology, exhibiting uniform round to epithelioid cells arranged in cords or nesting pattern in a fibromyxoid stroma. The OFMT with KDM2A-WWTR1 fusion involved dermis and superficial subcutis, being composed of ovoid cells in a fibromyxoid background with hyalinized giant rosettes. The S100 immunoreactivity ranged from very focal to absent. Similar to other known fusion genes in OFMT, BCORL1, CREBBP and KDM2A are also involved in histone modification. In summary, we expand the spectrum of molecular abnormalities in OFMT with 2 novel fusions, CREBBP-BCORL1 and KDM2A-WWTR1, further implicating the epigenetic deregulation as the leading pathogenetic mechanism in OFMT.

UR - http://www.scopus.com/inward/record.url?scp=84983611761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983611761&partnerID=8YFLogxK

U2 - 10.1002/gcc.22400

DO - 10.1002/gcc.22400

M3 - Article

VL - 56

SP - 42

EP - 50

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 1

ER -